PGIM India Healthcare Fund Regular G
Summary Info
Fund Name
: PGIM India Mutual Fund
Scheme Name
: PGIM India Healthcare Fund Regular G
AMC
: PGIM India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 19-Nov-2024
Fund Manager
: Anandha Padmanabhan Anjen
Net Assets (Rs. cr)
: 92.45
PGIM India Healthcare Fund Regular G - Nav Details
Nav Date
: 23-Mar-2026
NAV [Rs.]
: 9.49
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL
PGIM India Healthcare Fund Regular G- NAV Chart
PGIM India Healthcare Fund Regular G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -2.36 | -4.81 | -4.14 | -3.94 | 0.52 | - | - | -3.96 |
| Category Avg | -0.8 | -1.76 | -3.23 | -6.27 | 2.71 | 24.06 | 16.07 | 12.02 |
| Category Best | 0.64 | 0.25 | 0.44 | -2.36 | 8.69 | 28.11 | 18.74 | 25.56 |
| Category Worst | -1.47 | -3.39 | -7.14 | -10.49 | -4.23 | 19.54 | 11.97 | -8.28 |
PGIM India Healthcare Fund Regular G- Latest Dividends
No Records Found
PGIM India Healthcare Fund Regular G- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 11.69 | 62198 | 10.80 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 10.34 | 14919 | 9.56 |
| Equity | Aster DM Health. | Healthcare Services | 7.07 | 99839 | 6.53 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 6.39 | 28785 | 5.91 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 6.09 | 43771 | 5.63 |
| Equity | Max Healthcare | Healthcare Services | 5.81 | 49201 | 5.37 |
| Equity | Rubicon Research | Pharmaceuticals & Biotechnology | 5.29 | 62720 | 4.89 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 5.01 | 20595 | 4.62 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 4.94 | 15260 | 4.56 |
| Equity | Krishna Institu. | Healthcare Services | 4.35 | 53987 | 4.02 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 3.18 | 1108 | 2.93 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 3.17 | 6760 | 2.92 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.98 | 27636 | 2.75 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.83 | 18690 | 2.61 |
| Equity | Navin Fluo.Intl. | Chemicals & Petrochemicals | 2.81 | 4152 | 2.59 |
| Equity | Neuland Labs. | Pharmaceuticals & Biotechnology | 2.18 | 1574 | 2.01 |
| Equity | Jupiter Life Lin | Healthcare Services | 2.12 | 15520 | 1.95 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 2.08 | 27457 | 1.92 |
| Equity | Global Health | Healthcare Services | 1.95 | 15851 | 1.80 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 1.62 | 11122 | 1.49 |
| Equity | PB Fintech. | Financial Technology (Fintech) | 1.33 | 8308 | 1.23 |
| Equity | ICICI Lombard | Insurance | 1.26 | 6118 | 1.16 |
| Equity | Lenskart Solut. | Retailing | 0.78 | 13501 | 0.72 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.68 | 10285 | 0.63 |
| Equity | Sagility | IT - Services | 0.66 | 153674 | 0.60 |
| Equity | Dr Agarwal's Eye | Healthcare Services | 0.49 | 994 | 0.45 |
| Equity | Dr Agarwal's Hea | Healthcare Services | 0.46 | 9500 | 0.42 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
PGIM India Mutual Fund
Incorporation Date:
24-Sep-2008
Total Assets Managed (Cr.):
27,545.69
Trustee/s:
Rakesh Sood, PGIM India Trustees Priva, Mr. Vijay Agarwal, Mr. Sujal Shah, Mr. John Praveen, Mr. Ashwini Kakkar
Chairman:
NA
CEO / MD:
Ajit Menon, Abhishek Tiwari
CIO:
NA
President:
NA
Director/s:
Mr.Muralidharan Rajamani, Glenwyn Peter Baptist, Kapil Wadhawan, Mr.David Wan Chang, Mr.Indrasena Yala Reddy, Dr. V. R. Narasimham
Compliance Officer/s:
Mr. Sandeep Kamath, Mr. Sumesh Kumar
Investor Service Officer/s:
Murali Ramasubramanian
Fund Manager/s:
Anandha Padmanabhan Anjen
Auditors:
Price Waterhouse Chartere
OTHER INFORMATION
Registered Office:
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Contact Nos:
022-61593000
Fax:
022-61593100
Email:
Website:
